These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21603206)

  • 1. Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy.
    Hamilton JK; Conwell LS; Syme C; Ahmet A; Jeffery A; Daneman D
    Int J Pediatr Endocrinol; 2011; 2011(1):417949. PubMed ID: 21603206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.
    Müller HL; Bueb K; Bartels U; Roth C; Harz K; Graf N; Korinthenberg R; Bettendorf M; Kühl J; Gutjahr P; Sörensen N; Calaminus G
    Klin Padiatr; 2001; 213(4):244-9. PubMed ID: 11528558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma.
    Simoneau-Roy J; O'Gorman C; Pencharz P; Adeli K; Daneman D; Hamilton J
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):364-70. PubMed ID: 19486023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth in children with craniopharyngioma following surgery.
    Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.
    Van Gompel JJ; Nippoldt TB; Higgins DM; Meyer FB
    Neurosurg Focus; 2010 Apr; 28(4):E3. PubMed ID: 20367360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
    Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
    Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.
    Müller HL; Emser A; Faldum A; Bruhnken G; Etavard-Gorris N; Gebhardt U; Oeverink R; Kolb R; Sörensen N
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3298-305. PubMed ID: 15240606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interventions for the treatment of obesity in children and adolescents.
    Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary Approach for Hypothalamic Obesity in Children and Adolescents: A Preliminary Study.
    Tessaris D; Matarazzo P; Tuli G; Tuscano A; Rabbone I; Spinardi A; Lezo A; Fenocchio G; Buganza R; de Sanctis L
    Children (Basel); 2021 Jun; 8(7):. PubMed ID: 34206290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative dexamethasone treatment in childhood craniopharyngioma--influence on short-term and long-term weight gain.
    Müller HL; Heinrich M; Bueb K; Etavard-Gorris N; Gebhardt U; Kolb R; Sörensen N
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):330-4. PubMed ID: 14520598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain in craniopharyngioma--a model for hypothalamic obesity.
    Ahmet A; Blaser S; Stephens D; Guger S; Rutkas JT; Hamilton J
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):121-7. PubMed ID: 16562584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN.
    Mogul H; Freeman R; Nguyen K
    Endocr Pract; 2016 May; 22(5):575-86. PubMed ID: 26789348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs].
    Sterkenburg AS; Hoffmann A; Gebhardt U; Waldeck E; Springer S; Müller HL
    Klin Padiatr; 2014 Nov; 226(6-7):344-50. PubMed ID: 25431867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index.
    Trivin C; Busiah K; Mahlaoui N; Recasens C; Souberbielle JC; Zerah M; Sainte-Rose C; Brauner R
    BMC Pediatr; 2009 Apr; 9():24. PubMed ID: 19341477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.